▶ 調査レポート

世界の腹部ステントグラフトシステム市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Abdominal Stent Graft System Market - Growth, Trends, and Forecast(2022 - 2027)

Abdominal Stent Graft System Market - Growth, Trends, and Forecast(2022 - 2027)「世界の腹部ステントグラフトシステム市場2022年-2027年:成長・動向・新型コロナの影響・市場予測」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2203A587
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥703,000 (USD4,750)▷ お問い合わせ
  Site Licence¥962,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社は、世界の腹部ステントグラフトシステム市場規模が予測期間中に年平均4.1%成長すると予測しています。本調査資料では、腹部ステントグラフトシステムの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別(金属ステント、ポリマーステント)分析、エンドユーザー別(病院、外来手術センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の腹部ステントグラフトシステム市場規模:種類別(金属ステント、ポリマーステント)
・世界の腹部ステントグラフトシステム市場規模:エンドユーザー別(病院、外来手術センター、その他)
・世界の腹部ステントグラフトシステム市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争状況(Endologix, Inc.、Sofmedica、Terumo Corporation、Medtronic、Jotec GmbH、Cook medical、Microport、Scientific Corporation、Cardinal Health, Inc.)
・市場機会・将来の傾向

The Abdominal Stent Graft System market studied is expected to grow with an anticipated CAGR of 4.1%, during the forecast period.

The major factors attributing to the growth of the abdominal stent graft system market are increasing prevalence of abdominal aortic aneurysm, increase in geriatric population, increase in the population prone to risk of occlusive atherosclerosis disease, increasing adoption of minimally invasive surgeries, reduction in hospitalization period, availability of reimbursements and insurance coverage. The global increase in the number of geriatrics and varied life styles are likely to lead to consequences, which include exposure to risk factors such as smoking, high blood pressure, atherosclerosis and trauma.

As per the report by CDC, it is estimated that abdominal aortic aneurysm related complications are responsible for the death of 9928 people in United States, which accounts to approximately 3 death per 1,00,000. Abdominal aortic aneurysm was ranked as one of the top 15 causes for the death rate among geriatric population in the United Nations. The population aged 60 or above is growing at a rate of about 3% per year. It was estimated that Europe had the highest percentage of the population aged 60 or over in 2017. The annual new abdominal aortic aneurysm diagnoses is estimated to increase at a range of 0.4 to 0.67% in western countries. Hence, the rise in geriatric population and abdominal aortic aneurysm conditions act as major drivers for the growth of abdominal stent graft system market.

Key Market Trends

The Hospital segment from End User is expected to increase in the abdominal stent graft system market over the forecast period

There is an increase in the number of hospitals offering treatment based on the abdominal stent graft system and also estimated to exhibit an exponential increase in the healthcare professionals possessing expertise in performing surgeries based on the abdominal stent graft system. Also, most of the hospitals are being empaneled with the insurance providers and abdominal stent graft system market is expected to increase in the forecast period as it is covered by most of the insurance providers. Hence, the financial burden on patients shall be reduced. As per the American Health Association, the number of hospitals in the US has increased from 4985 to 5262 during the period of 2010-2017. This shows that the hospital number and the services are estimated to increase exponentially over the forecast period, thus driving the abdominal stent graft system market significantly.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the increasing incidence of abdominal aortic aneurysm, obesity, high blood pressure, rising geriatric population, growing adoption of the minimally invasive procedures, and growing physician and patient awareness about advanced technologies. In the North America region, the United States holds the largest market share. As per the Center for Disease Control and Prevention, it is estimated that aortic aneurysm is responsible for 9,928 deaths in 2017 and the history of smoking lead to 75% of abdominal aortic aneurysms. The US Preventive Services Task Force recommends men between 65-75 years of age and with smoking history should undergo ultrasound screening for abdominal aortic aneurysms. Hence, North America is expected to witness a healthy growth in abdominal stent graft system market over the forecast period.

Competitive Landscape

The abdominal stent graft system market is highly competitive and consists of significant major players. With the increasing levels of awareness and high prevalence of diseases, few other smaller players are expected to enter the market in the near future. Some of the major players of the market are Endologix, Inc., Sofmedica, Terumo Corporation, Medtronic, Jotec GmbH, Cook medical, Microport Scientific Corporation, Cardinal Health, Inc. and many others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Abdominal Aortic Aneurysm
4.2.2 Increase in the Geriatric Population and Risk of Occlusive Atherosclerotic Disease
4.2.3 Adoption to Minimal Invasive Surgeries and Minimal Hospitalization Period
4.3 Market Restraints
4.3.1 High Cost of Surgery and Treatment
4.3.2 Lack of Long Term Outcome Benefits
4.4 Porters Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Metal Stent
5.1.2 Polymer Stent
5.2 By End User
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Endologix, Inc.
6.1.2 Sofmedica
6.1.3 Terumo Corporation
6.1.4 Medtronic
6.1.5 Jotec GmbH
6.1.6 Cook medical
6.1.7 Microport Scientific Corporation
6.1.8 Cardinal Health, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS